0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Cancer Biomarkers
 1-20 of 226 Articles
JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Guo Chen, PhD; Jennifer L. McQuade, MD; David J. Panka, PhD; et al.
JAMA Oncol. Published online April 28, 2016. doi:10.1001/jamaoncol.2016.0509
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Sherene Loi, MD, PhD; Urania Dafni, ScD; Dimitris Karlis, PhD; et al.
JAMA Oncol. Published online April 21, 2016. doi:10.1001/jamaoncol.2016.0339
Includes: Supplemental Content

JAMA Oncology | 
Review |  ONLINE FIRST
Kevin Wood, MD; Thomas Hensing, MD; Raeva Malik, MD; et al.
JAMA Oncol. Published online April 21, 2016. doi:10.1001/jamaoncol.2016.0405
Includes: Supplemental Content

JAMA Otolaryngology–Head & Neck Surgery | 
Original Investigation |  ONLINE FIRST
Andrew C. Birkeland, MD; Megan Yanik, BS; Brittny N. Tillman, MD; et al.
JAMA Otolaryngol Head Neck Surg. Published online April 14, 2016. doi:10.1001/jamaoto.2016.0335
Includes: Supplemental Content

JAMA Oncology | 
Editorial |  ONLINE FIRST
Mark D. Pegram, MD
JAMA Oncol. Published online April 14, 2016. doi:10.1001/jamaoncol.2016.0238

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Ahmad Awada, MD, PhD; Ramon Colomer, MD, PhD; Kenichi Inoue, MD; et al.
JAMA Oncol. Published online April 14, 2016. doi:10.1001/jamaoncol.2016.0237
Includes: Supplemental Content

JAMA Oncology | 
Viewpoint |  ONLINE FIRST
Howard (Jack) West, MD
JAMA Oncol. Published online April 14, 2016. doi:10.1001/jamaoncol.2016.0075

JAMA Oncology | 
Viewpoint |  ONLINE FIRST
Vivek Subbiah, MD; Razelle Kurzrock, MD
JAMA Oncol. Published online April 14, 2016. doi:10.1001/jamaoncol.2016.0078

JAMA Oncology | 
Research Letter |  ONLINE FIRST
Rajesh C. Rao, MD; May P. Chan, MD; Christopher A. Andrews, PhD; et al.
JAMA Oncol. Published online April 07, 2016. doi:10.1001/jamaoncol.2016.0021

JAMA Oncology | 
Invited Commentary | 
Sean E. McGuire, MD, PhD
JAMA Oncol. 2016;2(4):480-481. doi:10.1001/jamaoncol.2015.4952.

JAMA Oncology | 
Original Investigation | 
Joseph R. Evans, MD, PhD; Shuang G. Zhao, MD; S. Laura Chang, PhD; et al.
JAMA Oncol. 2016;2(4):471-480. doi:10.1001/jamaoncol.2015.4955.
Includes: Supplemental Content

JAMA Dermatology | 
Brief Report | 
Mina S. Ally, MD; Katherine Ransohoff, BA; Kavita Sarin, MD, PhD; et al.
JAMA Dermatol. 2016;152(4):452-456. doi:10.1001/jamadermatol.2015.5473.
Includes: Supplemental Content

JAMA Internal Medicine | 
Research Letter | 
Michael E. Zavaski, MD; Christian P. Meyer, MD; Jesse D. Sammon, DO; et al.
JAMA Intern Med. 2016;176(4):546-547. doi:10.1001/jamainternmed.2015.7901.

JAMA Surgery | 
Original Investigation | 
Christina L. Roland, MD; Genevieve M. Boland, MD, PhD; Elizabeth G. Demicco, MD; et al.
JAMA Surg. 2016;151(4):347-354. doi:10.1001/jamasurg.2015.4205.
Includes: Supplemental Content

JAMA Dermatology | 
Original Investigation | 
Alan C. Geller, MPH, RN; Jonathan E. Mayer, MD, MPH; Arthur J. Sober, MD; et al.
JAMA Dermatol. 2016;152(4):413-418. doi:10.1001/jamadermatol.2016.0027.

JAMA Oncology | 
Editorial |  ONLINE FIRST
Hiten D. Patel, MD, MPH; Heather J. Chalfin, MD; H. Ballentine Carter, MD
JAMA Oncol. Published online March 31, 2016. doi:10.1001/jamaoncol.2016.0170

JAMA Oncology | 
Brief Report |  ONLINE FIRST
Bhavani Krishnan, PhD; Tracy L. Rose, MD, MPH; Jordan Kardos, BS; et al.
JAMA Oncol. Published online March 24, 2016. doi:10.1001/jamaoncol.2016.0005
Includes: Supplemental Content

JAMA Oncology | 
Research Letter |  ONLINE FIRST
Scott V. Bratman, MD, PhD; Jeffrey P. Bruce, PhD; Brian O’Sullivan, MD; et al.
JAMA Oncol. Published online March 24, 2016. doi:10.1001/jamaoncol.2015.6587

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Sosipatros A. Boikos, MD; Alberto S. Pappo, MD; J. Keith Killian, MD, PhD; et al.
JAMA Oncol. Published online March 24, 2016. doi:10.1001/jamaoncol.2016.0256
Includes: Supplemental Content

JAMA | 
JAMA Diagnostic Test Interpretation | 
Talal Hilal, MD; Edward H. Romond, MD
JAMA. 2016;315(12):1280-1281. doi:10.1001/jama.2015.17463.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Original Investigation  | 
Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor–Refractory Metastatic Melanoma A Phase 2 Clinical Trial
Guo Chen, PhD; Jennifer L. McQuade, MD; David J. Panka, PhD; et al.
JAMA Oncology
Original Investigation  | 
Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab A Secondary Analysis of the HERA Trial
Sherene Loi, MD, PhD; Urania Dafni, ScD; Dimitris Karlis, PhD; et al.
JAMA Oncology
Review  | 
Prognostic and Predictive Value in KRAS in Non–Small-Cell Lung Cancer A Review
Kevin Wood, MD; Thomas Hensing, MD; Raeva Malik, MD; et al.
JAMA Otolaryngology–Head & Neck Surgery
Original Investigation  | 
Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma
Andrew C. Birkeland, MD; Megan Yanik, BS; Brittny N. Tillman, MD; et al.